Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-04 Sale |
2025-02-05 4:02 pm |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO |
23,790 | $3.283 | $78,103 | 1,481,003 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 7:54 pm |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO |
10,164 | $2.3125 | $23,504 | 1,999,893 (Direct) |
View |
| 2021-02-09 Sale |
2021-02-10 5:06 pm |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer |
20,000 | $5 | $100,000 | 1,307,457 (Direct) |
View |
| 2020-12-14 Sale |
2020-12-16 4:33 pm |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer |
40,000 | $5.0008 | $200,032 | 1,327,457 (Direct) |
View |
| 2020-07-23 Sale |
2020-07-27 5:27 pm |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer |
20,000 | $5.01 | $100,200 | 1,367,457 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-14 Option Award |
2025-02-19 6:25 pm |
N/A 2035-02-14 |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO |
895,800 | $0 | 2,376,803 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:54 pm |
N/A 2034-02-01 |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO |
618,900 | $0 | 1,999,893 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:12 pm |
N/A 2033-02-01 |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer |
418,400 | $0 | 1,725,857 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-20 5:53 pm |
N/A 2032-01-20 |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer |
325,850 | $2.81 | 325,850 (Direct) |
View |
| 2021-02-13 Option Award |
2021-02-17 4:55 pm |
N/A 2031-02-13 |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Chief Business Officer |
249,000 | $0 | 249,000 (Direct) |
View |